Isomorphic Labs raises $2.1 Billion to scale its AI drug design engine

18-May-2026 - Isomorphic Labs, an AI-first drug design and development company, announced it has raised $2.1 Billion in Series B funding. This latest round of investment will accelerate the companyʼs evolution from pioneering novel AI models to applying them at scale. The financing round is led by Thrive ...

Virtual biology company secures $25m for virtual cell models

Turbine announces its first immunology partnership with a top 10 pharmaceutical company

04-Mar-2026 - Turbine announced a $25 million Series B financing, an expansion of its virtual cell platform across industries and a new immunology-focused partnership with a top 10 pharma company. The Series B round is led by Interactive Venture Partners, with participation from Beiersdorf AG and existing ...

Orbem secures €55.5 million Series B

Funding will accelerate Orbem's mission to solve global challenges by revealing what we can’t see on the outside of food and biology

22-Jan-2026 - Orbem, the Munich-based Deep tech company turning Magnetic Resonance Imaging (MRI) into a powerful, AI-powered tool to reveal hidden insights in food and biology, announced the successful closing of a €55.5 million Series B financing round. The round is led by European Deep tech specialist ...

StratifAI Raises €12.5M for Clinical Validation of AI Biomarker Platform for Precision Oncology

Oversubscribed round expand global reach, and unlock multi‑billion‑euro cancer diagnostics market

06-Oct-2025 - StratifAI, the AI biomarker company for precision oncology, has secured €12.5 million in an oversubscribed funding round. The funding will accelerate the clinical validation of its multimodal AI biomarker discovery platform, Polaris™. The round was led by Picus Capital, with co-lead Alven, ...

Berlin-based blood analysis innovator aescolab secures new capital

Start-up uses AI for personalized health analyses

23-Jun-2025 - aescolab, a Berlin-based healthtech innovator that uses AI to deliver personalized health analysis and lifestyle recommendations based on blood values, has closed a new round of funding to accelerate its growth. The investment will help the company grow its presence in Germany and expand into ...

Aignostics secures $34 million Series B to improve precision medicine with AI

Investments will support new product offerings, US expansion, and development of pathology foundation models

05-Nov-2024 - Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced that it has raised $34 million in Series B financing. This additional funding will be used to build new product offerings for biopharmaceutical clients, ...

€1.3M pre-seed funding for Lucid Genomics

Startup will use funds to fine-tune their AI models for diagnostics and biomarker discovery

05-Sep-2024 - The Berlin-based startup Lucid Genomics, a spin-off from the Max Planck Institute for Molecular Genetics and the Institute of Medical Genetics and Human Genetics at the Charité - Universitätsmedizin Berlin, has raised €1.3 million in pre-seed funding in a funding round led by Caesar Ventures, ...

Cloud-based platform for analyzing cryo-EM data secures pre-seed investment

Dutch biotech start-up aims to accelerate the development of new active ingredients

04-Mar-2024 - CryoCloud, a biotech start-up based in Utrecht in the Netherlands, recently closed a financing round of 500,000 euros. The company has thus reached an important milestone on its way to optimizing cryo-electron microscopy (cryo-EM). CryoCloud was founded in 2021 by Munich-based Robert Englmeier, ...

Highest-resolution view of subcellular, single-molecule, spatial biology

Resolve Biosciences Secures $71 Million Series B Financing

04-Nov-2022 - Resolve Biosciences announced it has secured a $71 million Series B financing. The latest round of funding was led by Patient Square Capital and included participation from EDBI, PS Capital, Alafi Capital, and NRW.BANK, as well as other existing investors. The company has now raised more than ...

Pioneers in observing single molecules in living cells closes $75 million Series B financing

Startup expands its management team and board of directors with the addition of several industry veterans

22-Feb-2022 - ONI, a biotechnology company democratizing the ability to observe single molecules in living cells with its desktop Nanoimager microscopy platform, announced the closing of a $75 million Series B financing. The round was led by ARCH Venture Partners and Casdin Capital, with participation from ...